Granahan Investment Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-86,416
| Closed | -$2.01M | – | 181 |
|
|
2024
Q3 | $2.01M | Sell |
86,416
-258,133
| -75% | -$5.99M | 0.08% | 171 |
|
|
2024
Q2 | $8.39M | Buy |
344,549
+8,402
| +2% | +$205K | 0.34% | 88 |
|
|
2024
Q1 | $11.4M | Sell |
336,147
-114,219
| -25% | -$3.86M | 0.4% | 74 |
|
|
2023
Q4 | $14.2M | Buy |
450,366
+51,504
| +13% | +$1.62M | 0.47% | 67 |
|
|
2023
Q3 | $10.2M | Buy |
+398,862
| New | +$10.2M | 0.36% | 85 |
|
|
2022
Q2 | – | Sell |
-64,851
| Closed | -$1.75M | – | 176 |
|
|
2022
Q1 | $1.75M | Buy |
64,851
+9,446
| +17% | +$255K | 0.04% | 169 |
|
|
2021
Q4 | $2.05M | Sell |
55,405
-17,772
| -24% | -$658K | 0.04% | 176 |
|
|
2021
Q3 | $3.5M | Buy |
+73,177
| New | +$3.5M | 0.07% | 170 |
|